Molecular genetic alterationsin malignant peripheral nervesheath tumors

References

• Woodruff JM, Selig AM, Crowley K, Allen PW. Schwannoma (neurilemoma) with malignant transformation. A rare, distinctive peripheral nerve tumor. Am. J. Surg. Path& 18, 882–895 (1994).
   Google Scholar
• McMenamin ME, Fletcher CD. Expanding the spectrum of malignant change in schwannomas: epithelioid malignant change, epithelioid malignant peripheral nerve sheath tumor and epithelioid angiosarcoma: a study of 17 cases. Am. J. Surg. Pathol 25(1), 13–25 (2001).
   Google Scholar
• Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57, 2006-2021 (1986).
   Google Scholar
• Hruban RII, Shiu MH, Senie RT, Woodruff JM. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 66,1253–1265 (1990).
   Google Scholar
• Perry A, Roth KA, Banerjee R, Fuller CE, Gutmann DH. NF1 deletions in 5–100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1) -associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am. J. Radial:159(1), 57–61 (2001).
   Google Scholar
• Gutmann DH, Collins FS. Von Recklinghausen neurofibromatosis. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA, 677–696 (1995).
   Google Scholar
• Xu G, O'Connell P, Viskochil D et al. The neurofibromatosis Type 1 gene encodes a protein related to GAP. Ce1162, 599–608 (1990).
   Google Scholar
• Gitler AD, Zhu Y, Ismat FA et al. NF1 has an essential role in endothelial cells. Nat. Genet. 33(1), 75–79 (2003).
   Google Scholar
• Basu TN, Gutmann DH, Fletcher JA, Glover TVV, Collins FS, Downward J. Aberrant regulation of ras proteins in malignant tumor cells from Type 1 neurofibromatosis patients. Nature 356(6371), 713–715 (1992).
   Google Scholar
• Hiatt KK, Ingram DA, Zhang Y, Bollag G, Clapp DW. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nfl -I- cells. Chem. 276(10), 7240–7245 (2001).
   Web of Science ®Google Scholar
• Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis Type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat. Genet. 3(2), 122–126 (1993).
   Google Scholar
• Cichowski K, Shih TS, Schmitt E et al Mouse models of tumor development in neurofibromatosis Type 1. Science 286(5447), 2172–2176 (1999).
   Google Scholar
• Wallace MR, Rasmussen SA, Lim IT, Gray BA, Zori RT, Muir D. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors. Genes Chromosomes Cancer 27(2), 117–123 (2000).
   Google Scholar
• Skuse GR, Kosciolek BA, Rowley PT Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis, loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer1(1), 36–41 (1989).
   Google Scholar
• Rasmussen SA, Overman J, Thomson SA et al Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis Type 1. Genes Chromosomes Cancer 28(4), 425–431 (2000).
   Google Scholar
• Rao UN, Surti U, Hoffner L, Yaw K Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue. Cancer Genet. Cytogenet. 88(1), 17–25 (1996).
   Google Scholar
• Gomez L, Barrios C, Kreicbergs A, Zetterberg A, Pestana A, Castresana JS. Absence of mutation at the GAP-related domain of the neurofibromatosis Type 1 gene in sporadic neurofibrosarcomas and other bone and soft tissue sarcomas. Cancer Genet. Cytogenet. 81(2), 173–174 (1995).
   Google Scholar
• Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 88(3), 323–331 (1997).
   Google Scholar
• Legius E, Dierick H, Wu R et al. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer 10 (4), 250–255 (1994).
   Google Scholar
• Lothe RA, Slettan A, Saeter G, Brogger A, Borresen AL, Nesland JM. Alterations at chromosome 17 loci in peripheral nerve sheath tumors. .1. Neumpathol. Exp. Neural. 54(1), 65–73 (1995).
   Google Scholar
• Menon AG, Anderson KM, Riccardi VM et al. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc. Natl Acad. Li USA 87(14), 5435–5439 (1990).
   Google Scholar
• Mawrin C, Kirches E, Boltze C, Dietzmann K, Roessner A, Schneider-Stock R. Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors. Virrhows krh. 440(6), 610–615 (2002).
   Google Scholar
• Leroy K, Dumas V, Martin-Garcia N et al. Malignant peripheral nerve sheath tumors associated with neurofibromatosis Type 1: a clinicopathologic and molecular study of 17 patients. Adb. Dermatol. 137(7), 908–913 (2001).
   Google Scholar
• Haling KC, Scheithauer BW, Halling AC et al. p53 expression in neurofibroma and malignant peripheral nerve sheath tumor. An immunohistochemical study of sporadic and NF1-associated tumors. Am. j Clin. Pathol. 106(3), 282–288 (1996).
   Google Scholar
• Strauss BL, Gutmann DH, Dehner LP et al Molecular analysis of malignant triton tumors. Hum. Athol. 30(8), 984–988 (1999).
   PubMed Web of Science ®Google Scholar
• Birindelli S, Perrone F, Oggionni M et al. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab. Invest. 81(6), 833–844 (2001).
   Google Scholar
• Jhanwar SC, Chen Q, Li FP, Brennan MF, Woodruff JM. Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet. 78(2), 138–144 (1994).
   Google Scholar
• Mechtersheimer G, Otano-Joos M, Ohl S et al. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer 25 (4), 362–369 (1999) .
   Google Scholar
• Gutmann DH, Sherman L, Seftor L, Haipek C, Hoang LK, Hendrix M. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. Hum. Mal Genet. 8(2), 267–275 (1999).
   Google Scholar
• Rey JA, Bello MJ, Kusak ME, de Campos JM, Pestana A. Involvement of 22q12 in a neurofibrosarcoma in neurofibromatosis Type 1. Cancer Genet. Cytogenet. 66(1), 28–32 (1993).
   Google Scholar
• Decker HJ, Cannizzaro LA, Mendez MJ et al Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study. Hum. Genet. 85(3), 337–342 (1990).
   Google Scholar
• Kindler-Rohrborn A, Kolsch BU, Fischer C, Held S, Rajewsky ME. Ethylnitrosourea-induced development of malignant schwannomas in the rat: two distinct loci on chromosome of 10 involved in tumor susceptibility and oncogenesis. Cancer Res. 59(5), 1109–1114 (1999).
   Google Scholar
• Nasir L, Rutteman GR, Reid SW Schulze C, Argyle DJ. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas. Cancer Lett. 174(1), 83–89 (2001).
   Google Scholar
• Berner JM, Sorlie T, Mertens F et al Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer26(2), 151–160 (1999).
   Google Scholar
• Kindblom LG, Ahlden M, Meis-Kindblom JM, Stenman G. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumors. Virchows krh. 427(1), 19–26 (1995).
   Google Scholar
• Watanabe T, Oda Y, Tamiya S, Kinukawa N, Masuda K, Tsuneyoshi M. Malignant peripheral nerve sheath tumors: high Ki67 labelling index is the significant prognostic indicator. Ifistopathology 39(2), 187–197 (2001).
   Google Scholar
• Kourea HP, Cordon-Cardo C, Dudas M, Leung D, Woodruff JM. Expression of p27 (kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27 (kip) in malignant transformation of neurofibromas. Am. j Pathol.155 (6), 1885–1891 (1999).
   Google Scholar
• Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/ CIP1 by a p53-independent pathway. Cancer Res. 54(13), 3391–3395 (1994).
   Google Scholar
• Kourea HP, Orlow I, Scheithauer BW, Cordon-Cardo C, Woodruff JM. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am. J Pathol 155 (6), 1855–1860 (1999).
   Google Scholar
• Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE, Louis DN. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am. J Pathol 155(6), 1879–1884 (1999).
   Google Scholar
• Perry A, Kunz SN, Fuller CE et al Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J. Neuropathol Exp. Neural. 61(8), 702–709 (2002).
   Google Scholar
• DeClue JE, Heffelfinger S, Benvenuto G et al Epidermal growth factor receptor expression in neurofibromatosis Type 1-related tumors and NF1 animal models. Clin. Invest. 105(9), 1233–1241 (2000).
   Google Scholar
• Miller SJ, Li H, Rizvi TA et al Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis. Mal Cell Biol. 23(6), 2213–2224 (2003).
   Google Scholar
• Li H, Velasco-Miguel S, Vass WC, Parada LF, DeClue JE. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the NF1:p53 mouse tumor model. Cancer Res. 62(15), 4507–4513 (2002).
   Google Scholar
• Hirose T, Scheithauer BW, Sano T Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. Am. J. Surg. Pathol 22(11), 1368–1378 (1998).
   Google Scholar
• Nagasaka T Lai R, Sone M, Nakashima T Nakashima N. Glandular malignant peripheral nerve sheath tumor: an unusual case showing histologically malignant glands. Arch. Path& Lab. Med 124(9), 1364–1368 (2000).
   Google Scholar
• King AA, Debaun MR, Riccardi VM, Gutmann DH. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am. J Med. Genet. 93(5), 388–392 (2000).
   Google Scholar
• Schmidt H, Wurl P, Taubert H et al. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer25(3), 205–211 (1999).
   Google Scholar
• Doom PF, MolenaarWM, Buter J, Hoekstra HJ. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur Surg OTICOi 21(1), 78–82 (1995).
   Google Scholar